Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vanessa E Kennedy

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Blood|February 5, 2026
Inclusion as innovation: broadening trial criteria in AMLVanessa E Kennedy, Lori Muffly
Expert Review of Hematology|January 12, 2019
Assessment of older adult candidates for allogeneic hematopoietic cell transplantation: updates and remaining questionsVanessa E Kennedy, Lori S Muffly
Frontiers in Oncology|January 11, 2021
<i>FLT3</i> Mutations in Acute Myeloid Leukemia: Key Concepts and Emerging ControversiesVanessa E Kennedy, Catherine C Smith
The Lancet. Haematology|October 8, 2021
Haematopoietic stem-cell transplantation in older adults: geriatric assessment, donor considerations, and optimisation of careVanessa E Kennedy, Rebecca L Olin
International Journal of Hematology|December 19, 2023
FLT3 targeting in the modern era: from clonal selection to combination therapiesVanessa E Kennedy, Catherine C Smith
The American Journal of Medicine|June 1, 2020
Marked Hyperbilirubinemia-Silent No More!Vanessa E Kennedy, Andrew D Leavitt, Patricia Cornett
British Journal of Haematology|September 6, 2024
Hybrid allogeneic bone marrow transplant rescue approach after acute myelogenous leukaemia relapse in a high-risk patientAlejandro Villar-Prados, Vanessa E Kennedy, Everett H Meyer
JCO Clinical Cancer Informatics|May 8, 2024
Advancing Readership Needs of the Clinical Cancer Informatics CommunityVanessa E Kennedy, Benjamin A Bates, Michael K Rooney
Ejhaem|April 27, 2026
Clonally Distinct FLT3-TKD Mutations in Host and Donor-Derived AML After Double Cord Blood Transplant: A Case ReportRebecca B Rojansky, Lisa Y Law, Bing M Zhang, et al.
The American Journal of Medicine|February 24, 2024
Monoclonal Gammopathy of Anemic Significance? Resolution of Pure Red Cell Aplasia With Daratumumab-Based TherapyOmar Khan, Sonam Prakash, Alfred Chung, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Blood|February 5, 2026
Inclusion as innovation: broadening trial criteria in AMLVanessa E Kennedy, Lori Muffly
Expert Review of Hematology|January 12, 2019
Assessment of older adult candidates for allogeneic hematopoietic cell transplantation: updates and remaining questionsVanessa E Kennedy, Lori S Muffly
Frontiers in Oncology|January 11, 2021
<i>FLT3</i> Mutations in Acute Myeloid Leukemia: Key Concepts and Emerging ControversiesVanessa E Kennedy, Catherine C Smith
The Lancet. Haematology|October 8, 2021
Haematopoietic stem-cell transplantation in older adults: geriatric assessment, donor considerations, and optimisation of careVanessa E Kennedy, Rebecca L Olin
International Journal of Hematology|December 19, 2023
FLT3 targeting in the modern era: from clonal selection to combination therapiesVanessa E Kennedy, Catherine C Smith
The American Journal of Medicine|June 1, 2020
Marked Hyperbilirubinemia-Silent No More!Vanessa E Kennedy, Andrew D Leavitt, Patricia Cornett
British Journal of Haematology|September 6, 2024
Hybrid allogeneic bone marrow transplant rescue approach after acute myelogenous leukaemia relapse in a high-risk patientAlejandro Villar-Prados, Vanessa E Kennedy, Everett H Meyer
JCO Clinical Cancer Informatics|May 8, 2024
Advancing Readership Needs of the Clinical Cancer Informatics CommunityVanessa E Kennedy, Benjamin A Bates, Michael K Rooney
Ejhaem|April 27, 2026
Clonally Distinct FLT3-TKD Mutations in Host and Donor-Derived AML After Double Cord Blood Transplant: A Case ReportRebecca B Rojansky, Lisa Y Law, Bing M Zhang, et al.
The American Journal of Medicine|February 24, 2024
Monoclonal Gammopathy of Anemic Significance? Resolution of Pure Red Cell Aplasia With Daratumumab-Based TherapyOmar Khan, Sonam Prakash, Alfred Chung, et al.
Pageof 5